Search results for: '20 pace'

The 20th annual World Diabetes Congress of the International Diabetic Federation mentions that India leads the world in the looming epidemic of diabetes. The concept of Self-Monitoring of Blood Glucose (SMBG) was introduced in India only a few years back, and the industry has already grown to about $49.7 million with a growth rate of over 20 per...

The multi-parameter patient monitoring market is growing at a healthy double-digit pace in Asia-Pacific, largely due to several macro indicators such as increasing healthcare expenditures and a growing number of private hospitals. There is an increasing trend in Southeast Asia towards the use of networked patient monitors using Wi-Fi and other netw...

This market insight aims to profile select medical device companies in Asia-Pacific for 2016. Research Scope: • The aim of this insight is to analyze and profile APAC medical device manufacturers, based on certain parameters. • It covers wound management, cardiovascular, orthopedic implants, infection control, and infusion the...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

23 Mar 2017  |  Asia Pacific  |  Market Research

APAC Molecular Diagnostics Market, Forecast to 2021

Pharmerging Economies with Rising Healthcare Demands will Accentuate Growth

Infographics

×

The molecular diagnostics (MDx) market in APAC is witnessing rapid growth due to two main factors: the high adoption of MDx tests for infectious diseases applications in emerging countries, and the advent of innovative diagnostic solutions in cancer and NGS based solutions that are gaining pace in Asia. Multinational companies have not only identif...